ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
2 announcements with these filters
Dr. Lal PathLabs announced the re-appointment of (Hony) Brig. Dr. Arvind Lal as Executive Chairman for five years from April 2027. The board also designated Dr. Reena Nakra and Dr. Saloni Khera as Senior Management Personnel and re-appointed Ernst & Young LLP as internal auditors for FY 2026-27.
Dr. Lal PathLabs Ltd informed exchanges that its Board meeting on April 30, 2026, will now also consider and recommend a Final Dividend for FY 2025-26. This is in addition to approving the audited financial results for the quarter and year ended March 31, 2026.